To explore the potential role of hepatic LCN2 in the development of PCB-induced NAFLD/NASH, we examined the effect of the in vitro knockdown of hepatic LCN2 using a siRNA delivery system. Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.